Literature DB >> 22068625

Arterial spin labeling of hemangioblastoma: differentiation from metastatic brain tumors based on quantitative blood flow measurement.

Koji Yamashita1, Takashi Yoshiura, Akio Hiwatashi, Osamu Togao, Koji Yoshimoto, Satoshi O Suzuki, Kazufumi Kikuchi, Masahiro Mizoguchi, Toru Iwaki, Hiroshi Honda.   

Abstract

INTRODUCTION: Hemangioblastoma and metastatic tumors are the major differential diagnoses for the posterior fossa tumors in adults. Our purpose was to evaluate the efficacy of ASL in differentiating hemangioblastomas from metastatic brain tumors.
METHODS: A total of 19 patients including 5 with a hemangioblastomas and 14 with metastatic tumors (7 from lung cancer, 4 from breast cancer, 1 from RCC, 1 from gastric cancer, and 1 from unknown origin) were enrolled in this study. ASL was performed using a pulsed ASL method at a 3-T unit. aTBF was measured as a mean absolute blood flow value within a region of interest drawn in the tumor. In addition, rTBF was obtained by normalizing the aTBF by a blood flow measured in the normal-appearing cortical gray matter. The aTBF and rTBF values were compared between hemangioblastomas and metastatic tumors using Student's t test.
RESULTS: Both the aTBF and rTBF values were significantly higher in hemangioblastomas (mean aTBF ± SD = 437 ± 274 mL/100 g/min, mean rTBF ± SD = 7.96 ± 3.12) in comparison with metastatic brain tumors (mean aTBF ± SD = 125 ± 134 mL/100 g/min, mean rTBF ± SD = 2.98 ± 3.91; p < 0.05, respectively). However, a metastasis from RCC showed very high aTBF (559 mL/100 g/min) and rTBF (16.2).
CONCLUSION: Our results demonstrated that ASL provides useful information to differentiate between hemangioblastomas and metastatic brain tumors. Metastasis from RCC may mimic hemangioblastoma on ASL blood flow measurement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068625     DOI: 10.1007/s00234-011-0977-5

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  25 in total

1.  Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging.

Authors:  D C Alsop; J A Detre; M Grossman
Journal:  Ann Neurol       Date:  2000-01       Impact factor: 10.422

2.  Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.

Authors:  Carsten Warmuth; Matthias Gunther; Claus Zimmer
Journal:  Radiology       Date:  2003-06-20       Impact factor: 11.105

3.  Model-free arterial spin labeling quantification approach for perfusion MRI.

Authors:  Esben Thade Petersen; Tchoyoson Lim; Xavier Golay
Journal:  Magn Reson Med       Date:  2006-02       Impact factor: 4.668

4.  Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features.

Authors:  H Kimura; H Takeuchi; Y Koshimoto; H Arishima; H Uematsu; Y Kawamura; T Kubota; H Itoh
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

5.  Volumetric cerebral perfusion imaging in healthy adults: regional distribution, laterality, and repeatability of pulsed continuous arterial spin labeling (PCASL).

Authors:  Adolf Pfefferbaum; Sandra Chanraud; Anne-Lise Pitel; Ajit Shankaranarayanan; David C Alsop; Torsten Rohlfing; Edith V Sullivan
Journal:  Psychiatry Res       Date:  2010-05-20       Impact factor: 3.222

Review 6.  Management of brain metastases.

Authors:  Riccardo Soffietti; Roberta Rudā; Roberto Mutani
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

7.  Follow-up study on metastatic cerebellar tumor surgery--characteristic problems of surgical treatment.

Authors:  K Kitaoka; H Abe; T Aida; M Satoh; T Itoh; Y Nakagawa
Journal:  Neurol Med Chir (Tokyo)       Date:  1990-08       Impact factor: 1.742

8.  Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.

Authors:  Domenico Catapano; Lucia Anna Muscarella; Vito Guarnieri; Leopoldo Zelante; Vincenzo Antonio D'Angelo; Leonardo D'Agruma
Journal:  Neurosurgery       Date:  2005-06       Impact factor: 4.654

Review 9.  Magnetic resonance imaging as a biomarker in renal cell carcinoma.

Authors:  Ivan Pedrosa; David C Alsop; Neil M Rofsky
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

Review 10.  Ultrastructure of cerebellar hemangioblastoma.

Authors:  A P Chaudhry; M Montes; G A Cohn
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

View more
  9 in total

1.  MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status.

Authors:  K Yamashita; A Hiwatashi; O Togao; K Kikuchi; R Hatae; K Yoshimoto; M Mizoguchi; S O Suzuki; T Yoshiura; H Honda
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-24       Impact factor: 3.825

2.  Added Value of Arterial Spin-Labeling MR Imaging for the Differentiation of Cerebellar Hemangioblastoma from Metastasis.

Authors:  K M Kang; C-H Sohn; S-H You; J G Nam; S H Choi; T J Yun; R-E Yoo; J-H Kim
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

3.  Pseudo-continuous arterial spin labeling reflects vascular density and differentiates angiomatous meningiomas from non-angiomatous meningiomas.

Authors:  Shinichiro Koizumi; Naoto Sakai; Hiroshi Kawaji; Yasuo Takehara; Shuhei Yamashita; Harumi Sakahara; Satoshi Baba; Hisaya Hiramatsu; Tetsuro Sameshima; Hiroki Namba
Journal:  J Neurooncol       Date:  2014-12-06       Impact factor: 4.130

4.  Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.

Authors:  Koji Yamashita; Takashi Yoshiura; Akio Hiwatashi; Osamu Togao; Koji Yoshimoto; Satoshi O Suzuki; Koichiro Abe; Kazufumi Kikuchi; Yasuhiro Maruoka; Masahiro Mizoguchi; Toru Iwaki; Hiroshi Honda
Journal:  Neuroradiology       Date:  2012-09-09       Impact factor: 2.804

5.  Measurement of the perfusion fraction in brain tumors with intravoxel incoherent motion MR imaging: validation with histopathological vascular density in meningiomas.

Authors:  Osamu Togao; Akio Hiwatashi; Koji Yamashita; Kazufumi Kikuchi; Daichi Momosaka; Koji Yoshimoto; Daisuke Kuga; Masahiro Mizoguchi; Satoshi O Suzuki; Toru Iwaki; Marc Van Cauteren; Koji Iihara; Hiroshi Honda
Journal:  Br J Radiol       Date:  2018-02-16       Impact factor: 3.039

Review 6.  A neuroradiologist's guide to arterial spin labeling MRI in clinical practice.

Authors:  M Grade; J A Hernandez Tamames; F B Pizzini; E Achten; X Golay; M Smits
Journal:  Neuroradiology       Date:  2015-09-09       Impact factor: 2.804

Review 7.  The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.

Authors:  Weilin Xu; Qun Wang; Anwen Shao; Bainan Xu; Jianmin Zhang
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

8.  Differentiating Between Low- and High-grade Glioma Tumors Measuring Apparent Diffusion Coefficient Values in Various Regions of the Brain.

Authors:  Farideh Momeni; Razzagh Abedi-Firouzjah; Zahra Farshidfar; Nastaran Taleinezhad; Leila Ansari; Ali Razmkon; Amin Banaei; Alireza Mehdizadeh
Journal:  Oman Med J       Date:  2021-03-31

9.  Hemangioblastoma of the Cerebellopontine Angle Evaluated with Pseudocontinuous Arterial Spin Labeling.

Authors:  Seiya Kishi; Masayuki Maeda; Ryota Kogue; Maki Umino; Toshio Matsubara; Hajime Sakuma
Journal:  Magn Reson Med Sci       Date:  2020-03-04       Impact factor: 2.471

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.